Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

812 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study.
Lo Gullo A, Becciolini A, Parisi S, Del Medico P, Farina A, Visalli E, Dal Bosco Y, Molica Colella AB, Lumetti F, Caccavale R, Scolieri P, Andracco R, Girelli F, Bravi E, Colina M, Volpe A, Ianniello A, Ditto MC, Nucera V, Franchina V, Platé I, Di Donato E, Amato G, Salvarani C, Bernardi S, Lucchini G, De Lucia F, Molica Colella F, Santilli D, Mansueto N, Ferrero G, Marchetta A, Arrigoni E, Foti R, Sandri G, Bruzzese V, Paroli M, Fusaro E, Ariani A. Lo Gullo A, et al. Among authors: salvarani c. J Clin Med. 2023 Jun 7;12(12):3892. doi: 10.3390/jcm12123892. J Clin Med. 2023. PMID: 37373587 Free PMC article.
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study.
Isca C, Spinella A, Toss A, de Pinto M, Ficarra G, Fabbiani L, Iannone A, Magnani L, Lumetti F, Macripò P, Vacchi C, Gasparini E, Piana S, Cortesi L, Maiorana A, Salvarani C, Dominici M, Giuggioli D. Isca C, et al. Among authors: salvarani c. J Pers Med. 2022 Dec 3;12(12):2007. doi: 10.3390/jpm12122007. J Pers Med. 2022. PMID: 36556228 Free PMC article.
Residual inflammation in psoriatic arthritis patients in stable minimal disease activity.
Macchioni P, Marchesoni A, Ciancio G, Sandri G, Zabotti A, Vukatana G, Montaguti L, Focherini M, Govoni M, Spinella A, Malavolta N, Zuliani F, Bruschi M, Mascella F, Salvarani C. Macchioni P, et al. Among authors: salvarani c. Front Med (Lausanne). 2022 Dec 20;9:1096547. doi: 10.3389/fmed.2022.1096547. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36606060 Free PMC article.
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study.
Venerito V, Manfredi A, Carletto A, Gentileschi S, Atzeni F, Guiducci S, Lavista M, La Corte L, Pedrollo E, Scardapane A, Tomassini C, Frediani B, Salvarani C, Iannone F, Sebastiani M. Venerito V, et al. Among authors: salvarani c. J Clin Med. 2023 Jan 26;12(3):957. doi: 10.3390/jcm12030957. J Clin Med. 2023. PMID: 36769604 Free PMC article.
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study.
Becciolini A, Parisi S, Del Medico P, Farina A, Visalli E, Molica Colella AB, Lumetti F, Caccavale R, Scolieri P, Andracco R, Girelli F, Bravi E, Colina M, Volpe A, Ianniello A, Ditto MC, Nucera V, Franchina V, Platè I, Donato ED, Amato G, Salvarani C, Bernardi S, Lucchini G, De Lucia F, Molica Colella F, Santilli D, Mansueto N, Ferrero G, Marchetta A, Arrigoni E, Foti R, Sandri G, Bruzzese V, Paroli M, Fusaro E, Ariani A. Becciolini A, et al. Among authors: salvarani c. Biomedicines. 2023 Feb 2;11(2):433. doi: 10.3390/biomedicines11020433. Biomedicines. 2023. PMID: 36830969 Free PMC article.
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano AM, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Pellagrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Guiducci S, Doria A, Salvarani C, Iannone F, Matucci-Cerinic M; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). De Angelis R, et al. Among authors: salvarani c. RMD Open. 2023 Mar;9(1):e002890. doi: 10.1136/rmdopen-2022-002890. RMD Open. 2023. PMID: 36868782 Free PMC article.
One-year clinical experience on the use of Nintedanib in systemic sclerosis.
Magnani L, Spinella A, Testoni S, Lumetti F, Scelfo C, Dardani L, Bajocchi G, Clini E, Salvarani C, Giuggioli D. Magnani L, et al. Among authors: salvarani c. Respirol Case Rep. 2023 May 23;11(6):e01120. doi: 10.1002/rcr2.1120. eCollection 2023 Jun. Respirol Case Rep. 2023. PMID: 37229296 Free PMC article.
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.
Magnani L, Ariani A, Lo Monaco A, Girelli F, Spinella A, Lumetti F, Reta M, Arrigoni E, Ursini F, Bezzi A, Cataleta P, Montaguti L, Trevisani M, Colina M, Bernardi S, De Pinto M, Galoppini G, Testoni S, Becciolini A, Pignataro F, Ciaffi J, Bravi E, Focherini M, Moscatelli S, Sambo P, Fusconi M, Corvaglia S, Bajocchi G, Conti D, Salvarani C, Giuggioli D. Magnani L, et al. Among authors: salvarani c. Acta Biomed. 2023 Aug 3;94(4):e2023148. doi: 10.23750/abm.v94i4.14317. Acta Biomed. 2023. PMID: 37539603 Free PMC article. Review.
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study.
Paroli M, Becciolini A, Bravi E, Andracco R, Nucera V, Parisi S, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Lo Gullo A, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, Di Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, Franchina V, Molica Colella F, Ferrero G, Ariani A. Paroli M, et al. Among authors: salvarani c. Medicina (Kaunas). 2023 Aug 17;59(8):1480. doi: 10.3390/medicina59081480. Medicina (Kaunas). 2023. PMID: 37629770 Free PMC article.
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.
Luchetti Gentiloni MM, Paci V, Carletto A, Zabotti A, Ramonda R, Chimenti MS, Dagna L, Luciano N, Piccinelli A, Giovannini I, Striani G, Boffini N, Sandri G, Possemato N, Pantano I, Benfaremo D, Salvarani C, Ciccia F, Selmi C, Moroncini G. Luchetti Gentiloni MM, et al. Among authors: salvarani c. Arthritis Res Ther. 2023 Oct 11;25(1):196. doi: 10.1186/s13075-023-03182-9. Arthritis Res Ther. 2023. PMID: 37821952 Free PMC article.
812 results